The Dundee site has modern facilities for the manufacture of Oral liquid products and Ectoparasiticides. The site also has micro-dose tube filling capabilities for Companion Animal products.  Argenta Dundee is currently supplying global markets and has both EMA and FDA registration.

We are responsible for providing support and advice in the following areas:

PRE-AWARD:

Direction to sources of funding and investment; intelligence & guidance on the priorities of external funding agencies; access to European Funding through identifi cation of new opportunities and potential partners including Framework RTD & ERDF.
Business development through marketing of the University’s expertise and resources; developing and cultivating links to researchers, industry and Government.
Effective negotiation of contracts on behalf of the University and academic staff.
POST-AWARD:

Intellectual property management, licensing & technology transfer.
Business planning & spin-out company formation.
Assistance to project managers in maximising performance and, therefore, facilitating the capture of repeat and new business.
RES, was established in 1998 to re-align and enhance St. Andrew’s research support services, to help researchers obtain and negotiate research contracts, to protect and manage the University’s IPR and direct and support all commercialisation activity and contracts including providing advice to potential spin-out entrepreneurs, to motivate fl edgling businesses, and champion their cause within the University. RES also provides information to the academic community through email at Resdesk, the RES web site and via individual meetings and seminars.

Ubiquigent is the partner chosen by many leading industry and academic organisations for their drug discovery programmes spanning the development of DUB inhibitors and modulators in the fields of protein degradation, stabilisation, and homeostasis.

Ubiquigent has an internal pipeline of drug discovery programmes and is developing a strong IP portfolio encompassing DUB inhibitors, DUB-targeting Proteolysis Targeting Chimeras (PROTACs) and DUB-Targeting Chimeras (DUBTACs) for subsequent commercialisation via partnerships and out-licensing agreements.  

The Company benefits from high calibre backing, including from IP Group PLC, Scottish Enterprise, the UK Medical Research Council (MRC) and the University of Dundee.

 

Capsule manufacture, epidural preparations, emergency drug boxes, eye drops, ointments & creams, large volume parenterals, oral liquids, IV additives, powders, oils, oral solutions, tablet & capsule packaging, parenteral nutrition services, topical liquids, small volume parenterals, sterile topicals. 

• SpheroMatrices®-our proprietary spheroid tissue microarray for obtaining medium-high throughput  toxicity/efficacy data from human-relevant organotypic spheroid cultures;
• Transcriptomic/Proteomic Profiling (RNA/protein) and bioinformatics for global assessment of possible modes of action and to support  human non-relevance arguments;
• Pathology Guided Image Analysis: quantifying immunostaining findings via bespoke algorithms, to provide resolving power to preclinical drug development and safety studies; can be combined with cell type-specific laser microdissection for enhanced resolution.

Bio-Formats and OMERO are the bridges that connect your image file formats to your image analysis software, plug-ins and bioinformatics solutions.Bio-Formats is the most comprehensive image translation library available with support for over 130 image file formats. We standardize your image files and let you view them where you want via OMERO. Concentrate on new discoveries while we worry about the framework.OMERO is a powerful interface that lets you view, share, analyze and publish data. It displays images translated by Bio-Formats and allows you to analyze them with your preferred software. Access your data from a local drive or remote servers and view it from anywhere, including your computer monitor, tablet device or smartphone.